This document provides guidance on the development of medicinal products for the treatment of epileptic disorders.

Keywords: Epilepsy, seizures, anti-epileptic agents

Current effective version

Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders - Revision 2

AdoptedReference Number: CHMP/EWP/566/98 Rev.2/Corr

English (EN) (248.78 KB - PDF)

First published: Last updated:
View

Document history - Revision 3

Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders - Revision 3

Consultation dates: to Draft: consultation openReference Number: CHMP/EWP/566/98 Rev. 3

English (EN) (997.26 KB - PDF)

First published: Last updated:
View

Concept paper on the need for revision of the guideline on clinical investigation of medicinal products in the treatment of epileptic disorders - Revision 2

Consultation dates: to Draft: consultation closedReference Number: EMA/CHMP/179692/2016

English (EN) (109.97 KB - PDF)

First published: Last updated:
View

Document history - Revision 2

Overview of comments received on 'Guideline on Clinical Investigation of Medicinal Products in the treatment of epileptic disorders' (CHMP/EWP/566/98 Rev.2) - Revision 2

Reference Number: EMA/611366/2009

English (EN) (127.27 KB - PDF)

First published: Last updated:
View

Draft guideline on clinical investigation of medicinal products in the treatment of epileptic disorders - Revision 2

Draft: consultation closedReference Number: CHMP/EWP/566/98 Rev. 2

English (EN) (200.42 KB - PDF)

First published: Last updated:
View

Recommendation of revision of the note for guidance on clinical investigation of medicinal products in treatment of epileptic disorders (CPMP/EWP/566/98 Rev. 1) - Revision 2

Reference Number: EMEA/CHMP/EWP/453780/2007

English (EN) (30.87 KB - PDF)

First published: Last updated:
View

Share this page